Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

NCT04929015 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT04929015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04929015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Not applicable
Overall status
Suspended
Start date
April 29, 2021
Completion date
September 1, 2027
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

appendix carcinoma by ajcc v8 stage, colorectal carcinoma by ajcc v8 stage, digestive system neoplasm, esophageal carcinoma by ajcc v8 stage, gastric carcinoma by ajcc v8 stage, liver and intrahepatic bile duct carcinoma, peritoneal carcinomatosis